Gaush Meditech (HKSE:02407) EPS (Diluted) : HK$1.28 (TTM As of Dec. 2023)

View and export this data going back to 2022. Start your Free Trial

What is Gaush Meditech EPS (Diluted)?

Gaush Meditech's Earnings per Share (Diluted) for the six months ended in Dec. 2023 was HK$0.46. Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was HK$1.28.

Gaush Meditech's EPS (Basic) for the six months ended in Dec. 2023 was HK$0.46. Its EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2023 was HK$1.28.

Gaush Meditech's EPS without NRI for the six months ended in Dec. 2023 was HK$0.44. Its EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2023 was HK$1.26.

During the past 3 years, the average EPS without NRIGrowth Rate was 3.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 5 years, Gaush Meditech's highest 3-Year average EPS without NRI Growth Rate was 3.80% per year. The lowest was 3.80% per year. And the median was 3.80% per year.

Gaush Meditech EPS (Diluted) Historical Data

The historical data trend for Gaush Meditech's EPS (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Gaush Meditech EPS (Diluted) Chart

Gaush Meditech Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

EPS (Diluted)

-0.28

0.80

-2.44

-4.03

1.28

Gaush Meditech Semi-Annual Data
	Dec19	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
EPS (Diluted)	Get a 7-Day Free Trial			-2.15	-0.41	-2.25	0.82	0.46

Competitive Comparison of Gaush Meditech's EPS (Diluted)

For the Medical Devices subindustry, Gaush Meditech's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Gaush Meditech's PE Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Gaush Meditech's PE Ratio distribution charts can be found below:

* The bar in red indicates where Gaush Meditech's PE Ratio falls into.

Gaush Meditech EPS (Diluted) Calculation

EPS (Diluted) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Diluted EPS takes into account all of the outstanding dilutive securities that could potentially be exercised (such as stock options and convertible preferred stock) and shows how such an action would impact earnings per share.

Gaush Meditech's Diluted EPS for the fiscal year that ended in Dec. 2023 is calculated as

Diluted EPS (A: Dec. 2023 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Diluted Average)
	=	(189.796	-	0)	/	148.029
	=	1.28

Gaush Meditech's Diluted EPS for the quarter that ended in Dec. 2023 is calculated as

Diluted EPS (Q: Dec. 2023 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Diluted Average)
	=	(0	-	0)	/	147.980
	=	0.00

EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$1.28

Gaush Meditech (HKSE:02407) EPS (Diluted) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Gaush Meditech EPS (Diluted) Related Terms

Thank you for viewing the detailed overview of Gaush Meditech's EPS (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.

Gaush Meditech (HKSE:02407) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Gaush Meditech Ltd (HKSE:02407) » Definitions » EPS (Diluted)

Comparable Companies

Traded in Other Exchanges

N/A

Address

No.11 Dongzhimen South Avenue, Room 1901, Building A, Zhonghui Plaza, Dongcheng District, Beijing, CHN

Website

https://www.gaush.com

Gaush Meditech Ltd is a provider of a broad spectrum of ophthalmic medical devices. The segments of the company include 1) Proprietary products segment develops and produces surgical equipment and related supporting software, intra-optical lens, ophthalmic disease diagnosis and treatment equipment and related supporting consumables independently; 2) Distribution products segment sells multi-function diagnostic equipment, ocular fundus diagnosis, surgical and treatment equipment and related supporting consumables produced by ophthalmic medical equipment manufacturers; 3) Technical services segment provides warranty services, maintenance services and after-sales services related consumables; and 4) Others segment.

Gaush Meditech (HKSE:02407) Headlines

No Headlines